Combination Therapy with Cyclosporin in Rheumatoid Arthritis
- 8 Downloads
During the last few years, there have been rapid developments in the drug treatment of rheumatoid arthritis. This has led to research into the role of combination therapy. While past combinations of slow-acting antirheumatic drugs have resulted in either an excessive number of adverse events or a lack of increased efficacy over single agent therapy, newer combinations appear to be more promising. It has recently been demonstrated that the combination of cyclosporin and methotrexate is more effective than methotrexate alone, with no increase in adverse effects. Improved trial methodology and a better understanding of the mechanism of action of these newer agents are assisting in the development of new combinations.
Unable to display preview. Download preview PDF.
- 1.Amor B, Herson D, Cherot A, et al. Follow-up study of patients with rheumatoid arthritis over a period of more than 10 years (1966–1978): analysis of disease progression and treatment in 100 cases. Ann Med Interne 1981; 132: 168–73.Google Scholar
- 4.Tiliakos NA. Low-dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: two years later [abstract] Arthritis Rheum 1986; 29: S79.Google Scholar
- 9.Haagsma C, Van Riel P, deRooij DJ, et al. Combination therapy in RA: sulphasalazine and methotrexate [abstract] Arthritis Rheum 1993; 36: S53.Google Scholar
- 10.O’Dell J, Haire C, Erikson N, et al. Triple DMARD therapy for rheumatoid arthritis: efficacy [abstract] Arthritis Rheum 1994; 37: S295.Google Scholar
- 14.Bensen W, Tugwell P, Roberts R, et al. Combination therapy of cyclosporin with methotrexate and gold in rheumatoid arthritis (2 pilot studies) [abstract] Arthritis Rheum 1994; 37: S335.Google Scholar
- 16.Stein CM, Pincus T, Brooks RH, et al. Combination therapy with cyclosporin and methotrexate: results of a 24 week extension study subsequent to a 24 week double-blind study [abstract] Arthritis Rheum 1994; 37: S252.Google Scholar
- 17.Landewé RBM, Miltenburg AMM, Breedveld FC, et al. Cyclosporin and chloroquine synergistically inhibit the interferon gamma production by CD4-positive and CD8-positive synovial T cell clones derived from a patient with rheumatoid arthritis. Cyclosporin in RA 1994; 111-23Google Scholar
- 18.Landewé RBM, Miltenburg AMM, Verdonk MJA, et al. Cyclosporin and chloroquine synergistically inhibit T cell proliferation by interference with IL-2 production and IL-2 responsiveness. Cyclosporin in RA 1994; 125-46Google Scholar